202 related articles for article (PubMed ID: 8453637)
1. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro.
Ozbun MA; Jerry DJ; Kittrell FS; Medina D; Butel JS
Cancer Res; 1993 Apr; 53(7):1646-52. PubMed ID: 8453637
[TBL] [Abstract][Full Text] [Related]
2. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
[TBL] [Abstract][Full Text] [Related]
3. p53 mutations in mouse mammary epithelial cells: instability in culture and discordant selection of mutations in vitro versus in vivo.
Ozbun MA; Medina D; Butel JS
Cell Growth Differ; 1993 Oct; 4(10):811-9. PubMed ID: 8274450
[TBL] [Abstract][Full Text] [Related]
4. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
Medina D; Kittrell FS; Oborn CJ; Schwartz M
Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
[TBL] [Abstract][Full Text] [Related]
5. Morphological and functional properties of TM preneoplastic mammary outgrowths.
Medina D; Kittrell FS; Liu YJ; Schwartz M
Cancer Res; 1993 Feb; 53(3):663-7. PubMed ID: 7678778
[TBL] [Abstract][Full Text] [Related]
6. Biological and genetic properties of the p53 null preneoplastic mammary epithelium.
Medina D; Kittrell FS; Shepard A; Stephens LC; Jiang C; Lu J; Allred DC; McCarthy M; Ullrich RL
FASEB J; 2002 Jun; 16(8):881-3. PubMed ID: 11967232
[TBL] [Abstract][Full Text] [Related]
7. Properties of mouse mammary epithelial cell lines characterized by in vivo transplantation and in vitro immunocytochemical methods.
Medina D; Oborn CJ; Kittrell FS; Ullrich RL
J Natl Cancer Inst; 1986 Jun; 76(6):1143-56. PubMed ID: 2423737
[TBL] [Abstract][Full Text] [Related]
8. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
9. Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro.
Kittrell FS; Oborn CJ; Medina D
Cancer Res; 1992 Apr; 52(7):1924-32. PubMed ID: 1372532
[TBL] [Abstract][Full Text] [Related]
10. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.
Ruggeri B; Caamano J; Goodrow T; DiRado M; Bianchi A; Trono D; Conti CJ; Klein-Szanto AJ
Cancer Res; 1991 Dec; 51(24):6615-21. PubMed ID: 1742735
[TBL] [Abstract][Full Text] [Related]
12. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
13. Expression of pregnancy-specific genes in preneoplastic mouse mammary tissues from virgin mice.
Smith GH; Vonderhaar BK; Graham DE; Medina D
Cancer Res; 1984 Aug; 44(8):3426-37. PubMed ID: 6430550
[TBL] [Abstract][Full Text] [Related]
14. The properties of p53 proteins selected for the loss of suppression of transformation.
Olson DC; Levine AJ
Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
[TBL] [Abstract][Full Text] [Related]
15. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
[TBL] [Abstract][Full Text] [Related]
16. P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog.
Van Leeuwen IS; Hellmèn E; Cornelisse CJ; Van den Burgh B; Rutteman GR
Anticancer Res; 1996; 16(6B):3737-44. PubMed ID: 9042250
[TBL] [Abstract][Full Text] [Related]
17. Sequential expression of preneoplastic and neoplastic characteristics of mouse mammary epithelial cells transformed in organ culture.
Iyer AP; Banerjee MR
J Natl Cancer Inst; 1981 May; 66(5):893-905. PubMed ID: 6785507
[TBL] [Abstract][Full Text] [Related]
18. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.
Lehman TA; Bennett WP; Metcalf RA; Welsh JA; Ecker J; Modali RV; Ullrich S; Romano JW; Appella E; Testa JR
Cancer Res; 1991 Aug; 51(15):4090-6. PubMed ID: 1855224
[TBL] [Abstract][Full Text] [Related]
20. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
